Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nineteen research firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have issued a buy rating on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $513.74.
A number of analysts recently weighed in on ISRG shares. Citigroup increased their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Royal Bank of Canada lifted their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday. Mizuho increased their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday. Finally, The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research report on Friday.
View Our Latest Research Report on ISRG
Insider Transactions at Intuitive Surgical
Hedge Funds Weigh In On Intuitive Surgical
Several hedge funds have recently modified their holdings of ISRG. Creekmur Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at approximately $26,000. Delos Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the last quarter. LRI Investments LLC bought a new stake in shares of Intuitive Surgical in the 1st quarter worth approximately $30,000. Finally, LGT Financial Advisors LLC lifted its stake in Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Price Performance
Intuitive Surgical stock opened at $521.15 on Friday. The business has a 50 day moving average of $483.85 and a 200-day moving average of $437.79. The company has a market capitalization of $184.85 billion, a P/E ratio of 94.07, a P/E/G ratio of 5.40 and a beta of 1.39. Intuitive Surgical has a 1 year low of $254.85 and a 1 year high of $523.34.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.24. The firm had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company’s revenue was up 14.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.18 EPS. Equities analysts anticipate that Intuitive Surgical will post 5.22 EPS for the current year.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- Learn Technical Analysis Skills to Master the Stock Market
- Survey Reveals: America’s Most Coveted Businesses in 2024
- Bank Stocks – Best Bank Stocks to Invest In
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.